AI Is Coming Up With Brand New Molecules, Fueling Drug Discovery

Key takeaways

AI technology is revolutionizing drug discovery, moving it from lunatic fringe ideas to mainstream science.
The ability to design proteins and resurrect lost antibiotics through AI presents new frontiers in combating diseases and toxins.
Overcoming skepticism and demonstrating real-world applicability has been crucial in gaining acceptance for AI in biology.
High-quality datasets are essential for the future success of AI applications in biotechnology, emphasizing the need for more preparatory work.
The partnership between human scientists and AI is pivotal, showcasing a collaborative future in scientific research.

Summary

The Rise of AI in Drug Discovery

The podcast discusses how the integration of AI into drug discovery has shifted from a fringe concept to a mainstream approach. Sports a dual narrative through groundbreaking studies in protein design and antibiotic discovery led by Dr. Cesar de La Fuente and Dr. David Baker. They share insights on how AI is utilized to create novel proteins that can neutralize toxic snake venom and resurrect antibiotics from extinct species, highlighting the transformative role AI plays in modern biomedicine.

Innovative Approaches to Create New Proteins

Dr. David Baker elaborates on the process of designing new proteins. By defining specific protein structures to target snake venom, their team employed AI to generate synthetic proteins tailored to bind efficiently to toxins, likening the process to a key fitting into a lock. This innovative approach allows for rapid experimental testing and iterative design, significantly speeding up the traditional processes of protein discovery.

Resurrecting Antibiotics from Extinct Species

Dr. Cesar de La Fuente shares the journey of using AI to discover and resurrect antibiotics derived from the genomes of extinct species, such as Neanderthals and woolly mammoths. This work draws on vast biological data and coding concepts to identify antibiotic-producing potential across evolutionary history, transforming how researchers approach antibiotic discovery.

Navigating Skepticism in Scientific Innovation

Both Dr. Baker and Dr. de La Fuente recount their early experiences with skepticism about using AI for biological research. They reflect on journeying from initial doubt within the scientific community to gaining traction and acceptance as their methods demonstrated success in real-world applications, indicating a broader shift towards acceptance of computational biology.

Future Prospects and Challenges in AI-Driven Biology

A discussion on the future trajectory of AI in drug design reveals hopes for more efficient antibiotic development processes and the necessity of high-quality datasets for continued advancements. Both experts express ambitions of transitioning their discoveries into clinical use, emphasizing the partnership between human decision-making and AI capabilities moving forward.

Show notes

A recent study in the journal Nature unveiled new proteins that can neutralize the deadliest of snake venoms. They’re “new” in that they aren’t found in nature—they were created in a lab, dreamed up by AI.

Using AI to discover, or design, the building blocks of drugs is a fast-growing area of research. Another team of scientists out of Philadelphia is using AI to discover new antibiotics by resurrecting long-lost molecules from extinct species like neanderthals and woolly mammoths.

We know what you’re thinking: It sounds too sci-fi to be true.

Flora Lichtman talks with two pioneers in the field about how AI is supercharging drug discovery: Dr. César de la Fuente, bioengineer and presidential associate professor at the University of Pennsylvania in Philadelphia, and Nobel laureate Dr. David Baker, director of the Institute for Protein Design and professor at the University of Washington in Seattle.

Transcripts for each segment will be available after the show airs on sciencefriday.com.

For our Los Angeles listeners: We’re working on a story about the toxins left behind by the fires and we want to hear from you. How is this affecting you? Are you worried about the air and water and soil? How are you approaching clean-up? And what questions do you have?

Leave us a voicemail at 1-646-767-6532 or send us an email at [email protected].

Subscribe to this podcast. Follow us on socials @ scifri on YouTube, Instagram, Facebook, TikTok, and Bluesky and sign up for our newsletters. Got a science question that’s keeping you up at night? Call us: 877-472-4374

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.